Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jean-Michel Molina

Hepatic Steatosis in HIV-HCV Coinfected Patients Receiving Antiretroviral Therapy Is Associated With HCV-related Factors but Not Antiretrovirals

BMC Research Notes

English

The Maraviroc Expanded Access Program — Safety and Efficacy Data From an Open-Label Study

HIV Clinical Trials

2015

English

Related publications

Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients

English

HCV Viremia Is Associated With Drug Use in Young HIV-1 and HCV Coinfected Pregnant and Non-Pregnant Women

English

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

BMC Infectious Diseases

Infectious Diseases

2020

English

Benefit of Direct-Acting Antiviral Therapy for Hepatitis C Virus (HCV) in Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Clinical Microbiology and Infection

English

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

HIV Clinical Trials

2009

English

Risk of Diabetes in HIV-infected Patients Is Associated With Cirrhosis but Not With Chronic HCV Coinfection in a French Nationwide HIV Cohort

Alimentary Pharmacology and Therapeutics

English

European Mitochondrial Haplogroups Predict Liver-Related Outcomes in Patients Coinfected With HIV and HCV: A Retrospective Study

Journal of Translational Medicine

English

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Journal of Medical Virology

Virology

Infectious Diseases

2012

English

All-Oral DAA Therapy Against HCV in HIV/HCV-coinfected Subjects in Real-World Practice: Madrid-CoRe Findings

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jean-Michel Molina

Hepatic Steatosis in HIV-HCV Coinfected Patients Receiving Antiretroviral Therapy Is Associated With HCV-related Factors but Not Antiretrovirals

The Maraviroc Expanded Access Program — Safety and Efficacy Data From an Open-Label Study

Related publications

Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients

HCV Viremia Is Associated With Drug Use in Young HIV-1 and HCV Coinfected Pregnant and Non-Pregnant Women

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

Benefit of Direct-Acting Antiviral Therapy for Hepatitis C Virus (HCV) in Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

Risk of Diabetes in HIV-infected Patients Is Associated With Cirrhosis but Not With Chronic HCV Coinfection in a French Nationwide HIV Cohort

European Mitochondrial Haplogroups Predict Liver-Related Outcomes in Patients Coinfected With HIV and HCV: A Retrospective Study

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

All-Oral DAA Therapy Against HCV in HIV/HCV-coinfected Subjects in Real-World Practice: Madrid-CoRe Findings